Kristen L Veraldi
Overview
Explore the profile of Kristen L Veraldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sellares J, Veraldi K, Thiel K, Cardenes N, Alvarez D, Schneider F, et al.
Am J Respir Cell Mol Biol
. 2018 Dec;
60(6):629-636.
PMID: 30543447
Idiopathic pulmonary fibrosis (IPF) pathogenesis has been postulated to involve a variety of mechanisms associated with the aging process, including loss of protein homeostasis (proteostasis). Heat shock proteins are cellular...
2.
Yoon J, Nouraie M, Chen X, Zou R, Sellares J, Veraldi K, et al.
Respir Res
. 2018 Oct;
19(1):195.
PMID: 30285867
Background: Lung Cancer is occasionally observed in patients with Idiopathic Pulmonary Fibrosis (IPF). We sought to describe the epidemiologic and clinical characteristics of lung cancer for patients with IPF and...
3.
Kitsios G, Rojas M, Kass D, Fitch A, Sembrat J, Qin S, et al.
Thorax
. 2017 Aug;
73(5):481-484.
PMID: 28802277
The microbiome has been proposed to play a role in the progression of idiopathic pulmonary fibrosis (IPF) based on bronchoalveolar lavage analyses, but the microbiome of lung tissue in IPF...
4.
Tan J, Tedrow J, Dutta J, Juan-Guardela B, Nouraie M, Chu Y, et al.
Am J Respir Crit Care Med
. 2016 Jun;
194(11):1392-1402.
PMID: 27310652
Rationale: Relaxin is a hormone that has been considered as a potential therapy for patients with fibrotic diseases. Objectives: To gauge the potential efficacy of relaxin-based therapies in idiopathic pulmonary...
5.
Schneider F, Veraldi K, Levesque M, Colby T, Yi E
Open Rheumatol J
. 2016 Apr;
10:33-8.
PMID: 27053971
We report a case of immunoglobulin(Ig)G4-related disease with the radiologic and histopathological manifestations resembling usual interstitial pneumonia (UIP). The patient was a 62-year-old man who presented with progressive dyspnea of...
6.
Schneider F, Murali R, Veraldi K, Tazelaar H, Leslie K
Arch Pathol Lab Med
. 2014 Jan;
138(2):257-65.
PMID: 24476522
Context: Patients with pneumothorax occasionally require limited lung resections to control persistent air leaks. In some patients, especially smokers, histopathologic findings suggest that a ruptured bulla or bleb caused the...
7.
Veraldi K, Feghali-Bostwick C
Open Rheumatol J
. 2012 Jul;
6:140-5.
PMID: 22802912
Fibrosis involves an orchestrated cascade of events including activation of fibroblasts, increased production and deposition of extracellular matrix components, and differentiation of fibroblasts into myofibroblasts. Epithelial-mesenchymal cross-talk plays an important...
8.
Yamaguchi Y, Takihara T, Chambers R, Veraldi K, Larregina A, Feghali-Bostwick C
Sci Transl Med
. 2012 Jun;
4(136):136ra71.
PMID: 22649092
Fibroproliferative disorders such as idiopathic pulmonary fibrosis and systemic sclerosis have no effective therapies and result in significant morbidity and mortality due to progressive organ fibrosis. We examined the effect...
9.
Brissett M, Veraldi K, Pilewski J, Medsger Jr T, Feghali-Bostwick C
Arthritis Rheum
. 2011 Sep;
64(1):272-80.
PMID: 21898349
Objective: To determine the role of insulin-like growth factor binding protein 3 (IGFBP-3) in mediating the effects of transforming growth factor β (TGFβ) on tenascin-C (TN-C) production and to assess...
10.
Veraldi K, Hsu E, Feghali-Bostwick C
Curr Rheumatol Rep
. 2010 Apr;
12(1):19-25.
PMID: 20425529
Interstitial lung disease is a frequent complication of systemic sclerosis and currently is the leading cause of death. Our ability to predict which individuals are at greatest risk of developing...